About Biomea Fusion (BMEA)
Biomea Fusion, Inc. operates as a biopharmaceutical company. The Company focuseS on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. Biomea Fusion serves customers i... Read more
- USD10.57
- USD10.90
- USD10.39
- USD43.69
- -27.90%
- --
- 35.00
- 1.00M
- 387M
- 8.13
- -65.30%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
